Lea Daniels Knight's most recent trade in Integra Lifesciences Holdings Corp was a trade of 5,226 Common Stock done at an average price of $18.0 . Disclosure was reported to the exchange on July 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.05 per share. | 03 Jul 2026 | 5,226 | 45,263 (0%) | 0% | 18.0 | 94,329 | Common Stock |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 111,179 | 111,179 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.61 per share. | 11 Mar 2026 | 8,089 | 50,489 (0%) | 0% | 9.6 | 77,735 | Common Stock |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.49 per share. | 03 Jul 2025 | 2,561 | 58,578 (0%) | 0% | 13.5 | 34,548 | Common Stock |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 44,171 | 44,171 | - | - | Non- Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 20,859 | 61,139 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.95 per share. | 11 Mar 2025 | 1,655 | 40,280 (0%) | 0% | 23.9 | 39,637 | Common Stock |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.73 per share. | 03 Jul 2024 | 2,561 | 41,935 (0%) | 0% | 28.7 | 73,578 | Common Stock |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 27,308 | 27,308 | - | - | Non- Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 11,822 | 36,213 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 8,283 | 44,496 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 18,293 | 18,293 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Lea Daniels Knight | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 6,098 | 24,391 (0%) | 0% | 0 | Common Stock |